Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICD coverage expansion

This article was originally published in The Gray Sheet

Executive Summary

CMS opens second 30-day public comment period May 25 to consider how results from St. Jude Medical's DEFINITE trial and Guidant's COMPANION study should influence the agency's review of a request for implantable cardioverter defibrillator coverage for the patient population in Medtronic's SCD-HeFT trial. While an initial comment period expired in April, the additional data was published May 20 (1"The Gray Sheet" May 24, 2004, p. 4). Comments are now due June 25. The agency's draft decision memo is due Sept. 30...
Advertisement

Related Content

Defibrillator Coverage Decision Will Weigh DEFINITE, COMPANION Trials
Defibrillator Coverage Decision Will Weigh DEFINITE, COMPANION Trials
Advertisement
UsernamePublicRestriction

Register

MT020318

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel